Terms: = Liver cancer AND ATF1, TREB36, 466, ENSG00000123268, P18846
156 results:
1. Performance evaluation of commercial and non-commercial shear wave elastography implementations for vascular applications.
Pruijssen JT; Schreuder FHBM; Wilbers J; Kaanders JHAM; de Korte CL; Hansen HHG
Ultrasonics; 2024 May; 140():107312. PubMed ID: 38599075
[TBL] [Abstract] [Full Text] [Related]
2. Dietary Exposure and Risk Assessment of Multi-Mycotoxins (AFB1, AFM1, OTA, OTB, DON, T-2 and HT-2) in the Lebanese Food Basket Consumed by Adults: Findings from the Updated Lebanese National Consumption Survey through a Total Diet Study Approach.
Hoteit M; Abbass Z; Daou R; Tzenios N; Chmeis L; Haddad J; Chahine M; Al Manasfi E; Chahine A; Poh OBJ; El Khoury A
Toxins (Basel); 2024 Mar; 16(3):. PubMed ID: 38535824
[TBL] [Abstract] [Full Text] [Related]
3. Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab.
Rimini M; Stefanini B; Tada T; Suda G; Shimose S; Kudo M; Finkelmeier F; Yoo C; Presa J; Amadeo E; Genovesi V; De Grandis MC; Iavarone M; Marra F; Foschi F; Tamburini E; Rossari F; Vitiello F; Bartalini L; Soldà C; Tovoli F; Vivaldi C; Lonardi S; Silletta M; Kumada T; Sakamoto N; Iwamoto H; Aoki T; Himmelsbach V; Montes M; Hiraoka A; Sho T; Niizeki T; Nishida N; Steup C; Hirooka M; Kariyama K; Tani J; Atsukawa M; Takaguchi K; Itobayashi E; Fukunishi S; Tsuji K; Ishikawa T; Tajiri K; Ochi H; Yasuda S; Toyoda H; Ogawa C; Nishimura T; Hatanaka T; Kakizaki S; Shimada N; Kawata K; Tada F; Ohama H; Nouso K; Morishita A; Tsutsui A; Nagano T; Itokawa N; Okubo T; Arai T; Imai M; Kosaka H; Naganuma A; Koizumi Y; Nakamura S; Kaibori M; Iijima H; Hiasa Y; Persano M; Camera S; Foti S; Aldrighetti L; Cascinu S; Casadei-Gardini A; Piscaglia F
Liver Int; 2024 May; 44(5):1108-1125. PubMed ID: 38517286
[TBL] [Abstract] [Full Text] [Related]
4. [Net survival analysis of cancer in Zhongshan City of Guangdong Province in China, 1970 to 2014].
Li ZM; Liang ZH; Liu N; Wei KR
Zhonghua Zhong Liu Za Zhi; 2024 Mar; 46(3):232-238. PubMed ID: 38494769
[No Abstract] [Full Text] [Related]
5. [cancer incidence and mortality in China, 2022].
Zheng RS; Chen R; Han BF; Wang SM; Li L; Sun KX; Zeng HM; Wei WW; He J
Zhonghua Zhong Liu Za Zhi; 2024 Mar; 46(3):221-231. PubMed ID: 38468501
[No Abstract] [Full Text] [Related]
6. Automatic segmentation of hepatocellular carcinoma on dynamic contrast-enhanced MRI based on deep learning.
Luo X; Li P; Chen H; Zhou K; Piao S; Yang L; Hu B; Geng D
Phys Med Biol; 2024 Mar; 69(6):. PubMed ID: 38330492
[No Abstract] [Full Text] [Related]
7. Global incidence of adverse clinical events in non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Le MH; Le DM; Baez TC; Dang H; Nguyen VH; Lee K; Stave CD; Ito T; Wu Y; Yeo YH; Ji F; Cheung R; Nguyen MH
Clin Mol Hepatol; 2024 Apr; 30(2):235-246. PubMed ID: 38281814
[TBL] [Abstract] [Full Text] [Related]
8. Can incorporating genotyping data into efficacy estimators improve efficiency of early phase malaria vaccine trials?
Potter GE; Callier V; Shrestha B; Joshi S; Dwivedi A; Silva JC; Laurens MB; Follmann DA; Deye GA
Malar J; 2023 Dec; 22(1):383. PubMed ID: 38115002
[TBL] [Abstract] [Full Text] [Related]
9. Weekend Effect on Clinical Outcomes of Acute Lower Gastrointestinal Bleeding: A Large Multicenter Cohort Study in Japan.
Hayasaka J; Kikuchi D; Ishii N; Kobayashi K; Yamauchi A; Yamada A; Omori J; Ikeya T; Aoyama T; Tominaga N; Sato Y; Kishino T; Sawada T; Murata M; Takao A; Mizukami K; Kinjo K; Fujimori S; Uotani T; Fujita M; Sato H; Suzuki S; Narasaka T; Funabiki T; Kinjo Y; Mizuki A; Kiyotoki S; Mikami T; Gushima R; Fujii H; Fuyuno Y; Gunji N; Toya Y; Narimatsu K; Manabe N; Nagaike K; Kinjo T; Sumida Y; Funakoshi S; Kobayashi K; Matsuhashi T; Komaki Y; Miki K; Watanabe K; Odagiri H; Hoteya S; Kaise M; Nagata N
Dig Dis; 2023; 41(6):890-899. PubMed ID: 37669627
[TBL] [Abstract] [Full Text] [Related]
10. Second Primary cancer Among Patients With Papillary Thyroid Carcinoma Following the Chernobyl Disaster.
Taha A; Taha-Mehlitz S; Nadyrov EA; Zinovkin D; Veyalkin I; Levin L; Pranjol MZI; Melling N; Honaker MD; Cattin PC; Schmid RA
JAMA Netw Open; 2023 Aug; 6(8):e2329559. PubMed ID: 37589974
[TBL] [Abstract] [Full Text] [Related]
11. [Malignant gastrointestinal neuroectodermal tumor: a clinicopathological analysis of three cases].
Fan CY; Wang YX; Hu PZ; Yang SJ
Zhonghua Bing Li Xue Za Zhi; 2023 Aug; 52(8):791-796. PubMed ID: 37527982
[No Abstract] [Full Text] [Related]
12. Age-specific cardiovascular disease-related mortality among patients with major gastrointestinal cancers: A SEER population-based study.
Liu G; Zhang BF
Cancer Med; 2023 Aug; 12(16):17253-17265. PubMed ID: 37387603
[TBL] [Abstract] [Full Text] [Related]
13. Population-based impact of COVID-19 on incidence, treatment, and survival of patients with pancreatic cancer.
Graus MUJE; de Hingh IHJT; Besselink MG; Bruno MJ; Wilmink JW; de Meijer VE; van Velthuysen MF; Valkenburg-van Iersel LBJ; van der Geest LGM; de Vos-Geelen J; ; ;
HPB (Oxford); 2023 Oct; 25(10):1195-1202. PubMed ID: 37236831
[TBL] [Abstract] [Full Text] [Related]
14. Impact of COVID-19 lockdowns on postoperative morbidity after hepatectomy: A propensity-score matching study on a national French database.
Nassar A; Tzedakis S; Marchese U; Dhote A; Dallel MS; Naveendran G; Gaillard M; Coriat R; Marty JR; Fuchs B; Fuks D
Surgery; 2023 Aug; 174(2):196-202. PubMed ID: 37150714
[TBL] [Abstract] [Full Text] [Related]
15. Extraenteric Malignant Gastrointestinal Neuroectodermal Tumor-A Clinicopathologic and Molecular Genetic Study of 11 Cases.
Ulici V; Hornick JL; Davis JL; Mehrotra S; Meis JM; Halling KC; Fletcher CDM; Kao E; Folpe AL
Mod Pathol; 2023 Jul; 36(7):100160. PubMed ID: 36934861
[TBL] [Abstract] [Full Text] [Related]
16. Development and validation of robust metabolism-related gene signature in the prognostic prediction of hepatocellular carcinoma.
Pan Y; Zhang D; Chen Y; Li H; Wang J; Yuan Z; Sun L; Zhou Z; Chen M; Zhang Y; Hu D
J Cell Mol Med; 2023 Apr; 27(7):1006-1020. PubMed ID: 36919714
[TBL] [Abstract] [Full Text] [Related]
17. Time trends and geographic distribution of hepatocellular carcinoma in Brazil: An ecological study.
Balbi E; Moreira JPL; Luiz RR; Perez RM; de Souza HSP
Medicine (Baltimore); 2022 Sep; 101(38):e30614. PubMed ID: 36197232
[TBL] [Abstract] [Full Text] [Related]
18. TED: Two-stage expert-guided interpretable diagnosis framework for microvascular invasion in hepatocellular carcinoma.
Zhou Y; Sun SW; Liu QP; Xu X; Zhang Y; Zhang YD
Med Image Anal; 2022 Nov; 82():102575. PubMed ID: 36063747
[TBL] [Abstract] [Full Text] [Related]
19. Comparing Predictability of Non-invasive Tools for Hepatocellular Carcinoma in Treated Chronic Hepatitis C Patients.
Liu YC; Cheng YT; Chen YC; Hsieh YC; Jeng WJ; Lin CY; Chien RN; Tai DI; Sheen IS
Dig Dis Sci; 2023 Jan; 68(1):323-332. PubMed ID: 35895234
[TBL] [Abstract] [Full Text] [Related]
20. Potential of circulating lncRNA CASC2 as a biomarker in reflecting the inflammatory cytokines, multi-organ dysfunction, disease severity, and mortality in sepsis patients.
Wang R; Zhao J; Wei Q; Wang H; Zhao C; Hu C; Han Y; Hui Z; Yang L; Dai Q; Liu C
J Clin Lab Anal; 2022 Aug; 36(8):e24569. PubMed ID: 35754113
[TBL] [Abstract] [Full Text] [Related]
[Next]
